CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 79 enrolled
Drug / intervention
EZ close +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03374189
NCT03374189N/ACompleted

Single Blind Randomized Control Trial Evaluating Efficacy and Safety of EZ-Close Port-site Closure Device Versus Carter-Thomason Device

Saint Vincent's Hospital, Korea·interventional·Posted Dec 15, 2017·Updated Mar 1, 2019

In Brief

A clinical study evaluating EZ close and Carter Thomason for Surgical Port Site Hernia. Completed, enrolled 79 participants across 1 site.

Detailed Summary

This study aims to evaluate the efficacy and safety of a novel port-site closure device (EZ Close) by comparing it with the Carter-Thomason device.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesSouth Korea
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedDec 15, 2017
Enrollment StartAug 17, 2017
Primary CompletionMay 9, 2018
Study CompletionMay 24, 2018
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 8.5 years ago

Interventions

EZ closedevice

EZ close used.

Carter Thomasondevice

Carter Thomason used.